Electrochemotherapy: Aspects of preclinical development and early clinical experience

Annals of Surgery

Volumn 245, Issue 3, 2007, Pages 469-479

  Larkin, John O ^a   Collins, Christopher G ^a   Aarons, Simon ^a   Tangney, Mark ^a   Whelan, Maria ^a   O'Reily, Seamus ^a   Breathnach, Oscar ^a   Soden, Declan M ^a   O'Sullivan, Gerald C ^a  

^a MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BLEOMYCIN SULFATE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROL GROUP; CONTROLLED STUDY; CYTOTOXICITY; DRUG TREATMENT FAILURE; ELECTRICITY; ELECTROCHEMOTHERAPY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PATIENT SAFETY; PRIORITY JOURNAL; REPRODUCIBILITY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STANDARD; STATISTICAL SIGNIFICANCE; SYNOVIAL SARCOMA; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; CARCINOMA, SQUAMOUS CELL; ELECTROCHEMOTHERAPY; FEMALE; FINITE ELEMENT ANALYSIS; HUMANS; KIDNEY NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 34247576877     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000250419.36053.33     Document Type: Article

References (44)

1. Mir LM, Orlowski S, Belehradek J Jr, et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer. 1991;27:68-72.
2. Belehradek J Jr, Orlowski S, Poddevin B, et al. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer. 1991;27:73-76.
3. Belehradek M, Domenge C, Luboinski B, et al. Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial. Cancer. 1993;72:3694-3700.
4. Mir LM, Belehradek M, Domenge C, et al. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III. 1991;313:613-618.
5. Neumann E, Schaefer-Ridder M, Wang Y, et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982;1:841-845.
6. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res. 1988;175:15-25.
7. Teruel MN, Blanpied TA, Shen K, et al. A versatile microporation technique for the transfection of cultured CNS neurons. J Neurosci Methods. 1999;93:37-48.
8. Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs. 1998;9:319-325.
9. Belehradek J Jr, Orlowski S, Ramirez LH, et al. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta. 1994;1190:155-163.
10. Jaroszeski MJ, Dang V, Pottinger C, et al. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 2000;11:201-208.
11. Gehl J, Sorensen TH, Nielsen K, et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta. 1999;1428:233-240.
12. Engstrom PE, Persson BR, Salford LG. Studies of in vivo electropermeabilization by gamma camera measurements of (99m)Tc-DTPA. Biochim Biophys Acta. 1999;1473:321-328.
13. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 1995;55:3450-3455.
14. Rols MP, Delteil C, Golzio M, et al. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol. 1998;16:168-171.
15. Mir LM, Orlowski S, Belehradek J, et al. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrochem Bioenergetics. 1995;38:203-207.
16. Langer R. New methods of drug delivery. Science. 1990;249:1527-1533.
17. Orlowski S, Belehradek J Jr, Paoletti C, et al. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol. 1988;37:4727-4733.
18. Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res. 2000;10:585-589.
19. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, et al. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res. 2001;32:273-276.
20. Allegretti JP, Panje WR. Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope. 2001;111:52-56.
21. Rols MP, Bachaud JM, Giraud P, et al. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res. 2000;10:468-474.
22. Glass LF, Pepine ML, Fenske NA, et al. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol. 1996;132:1353-1357.
23. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996;77:964-971.
24. Sersa G, Cufer T, Cemazar M, et al. Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review. Tumori. 2000;86:163-165.
25. Kubota Y, Mir LM, Nakada T, et al. Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol. 1998;160:1426.
26. Heller R, Jaroszeski MJ, Reintgen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148-157.
27. Domenge C, Orlowski S, Luboinski B, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 1996;77:956-963.
28. Burian M, Formanek M, Regele H. Electroporation therapy in head and neck cancer. Acta Otolaryngol. 2003;123:264-268.
29. Soden DM, Larkin JO, Collins CG, et al. Successful application of electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumors. Cancer Letters. 2006;232:300-310.
30. WHO Handbook for Reporting Results of Cancer Treatment, vol. 48. Geneva: WHO Offset, 1979:22-27.
31. Lazo J. Bleomycin. In: Chabner B, ed. Cancer Chemotherapy and Biotherapy. Philadelphia: Lippincott-Raven, 1996:379-393.
32. Poddevin B, Orlowski S, Belehradek J Jr, et al. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol. 1991;42(suppl):67-75.
33. Tounekti O, Pron G, Belehradek J Jr, et al. Bleomycin, an apoptosismimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 1993;53:5462-5469.
34. Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol. 1996;27:745-748.
35. Roy SN, Horwitz SB. Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. Cancer Res. 1984;44:1541-1546.
36. Sersa G, Beravs K, Dodd NJF, et al. Electric current density imaging of mice tumors. Magnetic Reson Med. 1997;37:404-409.
37. Mir LM, Orlowski S, Poddevin B, et al. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw. 1992;3:331-334.
38. Collins C, Tangney M, Larkin J, et al. Local gene therapy of solid tumors with GMCSFand B7-1 eradicates both treated and distal tumors. Cancer Gene Therapy. In press.
39. Lebar AM, Sersa G, Kranjc S, et al. Optimisation of pulse parameters in vitro for in vivo electrochemotherapy. Anticancer Res. 2002;22:1731-1736.
40. Gehl JT, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta. 2002;1569:51-58.
41. Engstrom PE, Ivarsson K, Tranberg KG, et al. Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver. Anticancer Res. 2001;21:1817-1822.
42. Sersa GK, Beravs K, Cemazar M. Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro-Magnetobiol 1998;17:299-306.
43. Sersa GM, Cemazar D, Miklavcic D, et al. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res. 1999;19:4017-4022.
44. Sersa GM, Cemazar D, Parkins CS, et al. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer. 1999;35:672-677.